CONNECT WITH US
Web3 & Blockchain

Web3 & Blockchain

INJ Price Prediction: MACD Flatlines at Zero — $8.07 Test or $7.08 Breakdown Imminent

Blockchain.News logo

Published on

Add as a preferred source on Google
INJ Price Prediction: MACD Flatlines at Zero — $8.07 Test or $7.08 Breakdown Imminent

INJ is trading at $7.45 with its MACD histogram frozen at dead zero — a rare momentum inflection that gives bulls and bears exactly 48–72 hours to prove their case. Smart money is leaning long, but...

Market analysis includes conditional scenarios, not assured price outcomes or investment advice. Check the data, assumptions and dates cited.

Injective is sitting at $7.45 as of 09:14 UTC on October 7, 2026, and the chart is telling a story of total indecision. A -2.96% drop in the past 24 hours has pushed INJ below both its 7-day SMA ($7.63) and 20-day SMA ($7.68), slipping the price into the lower third of its Bollinger Band range. The session's low of $7.33 came dangerously close to testing the $7.08 immediate support — a level that, if broken convincingly, opens a fast path toward $6.71.

What makes this setup genuinely interesting, not just another pullback, is the context of the longer-term trend. The 50-day SMA sits at $6.31 and the 200-day at $4.91. INJ has nearly doubled off its long-term base. That structural bid is real. But right now, the short-term tape is running out of oxygen — and the momentum oscillators are screaming that a resolution is coming fast. As Blockchain.news has tracked across Layer-1 DeFi names, this kind of compression after a multi-month recovery run almost always resolves with a sharp directional move, not a slow grind.

0000. Not slightly positive, not slightly negative — flat zero. 20 respectively) have achieved perfect equilibrium, and the next histogram candle will declare a winner.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.